Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara 2591193, Kanagawa, Japan.
Department of Gastroenterology, Tokai University School of Medicine, Isehara 2591193, Kanagawa, Japan.
World J Gastroenterol. 2020 Nov 14;26(42):6698-6705. doi: 10.3748/wjg.v26.i42.6698.
The commonest sites of extrahepatic metastases from hepatocellular carcinoma (HCC) are the lungs, bones, adrenal glands, and regional lymph nodes. Hematogenous metastasis to the gastrointestinal (GI) tract is a rare condition in patients with HCC, and the prognosis is usually poor. We report, herein, an extremely rare case of a patient with intussusception due to hematogenous metastasis of HCC to the ileum and his long-term survival with multidisciplinary therapy.
The patient was a 71-year-old man with a history of chronic hepatitis B, who had undergone three surgeries for HCC. He was treated with sorafenib for peritoneal metastases of HCC. He was admitted to our hospital with chief complaints of abdominal pain and vomiting. Abdominal contrast-enhanced computed tomography imaging revealed a small intestinal tumor, presenting with intussusception and small bowel obstruction. Conservative treatment was started, but due to repeated exacerbation of symptoms, surgery was planned on the 28 d of hospitalization. Partial ileal resection without reducing the intussusception and end-to-end anastomosis was performed. On histological examination, tumor cells were not observed on the serosal surface, but intravascular invasion of tumor cells was seen. Immunohistochemistry was positive for immunohistochemical markers, and a diagnosis of hematogenous metastasis of HCC to the ileum was made. He remains alive 82 mo after the first surgery.
Prognosis of HCC patients with GI tract metastasis is usually poor, but in some cases, multidisciplinary therapy may prolong survival.
肝细胞癌(HCC)肝外转移最常见的部位是肺部、骨骼、肾上腺和局部淋巴结。HCC 血行转移至胃肠道(GI)是一种罕见的情况,预后通常较差。我们在此报告一例 HCC 血行转移至回肠引起肠套叠的极罕见病例,并通过多学科治疗获得长期生存。
患者为 71 岁男性,有慢性乙型肝炎病史,曾因 HCC 行 3 次手术,因 HCC 腹膜转移接受索拉非尼治疗。因腹痛和呕吐就诊,入院时诉腹痛和呕吐。腹部增强 CT 影像学检查显示小肠肿瘤,表现为肠套叠和小肠梗阻。开始保守治疗,但由于症状反复加重,在住院第 28 天行手术治疗。未进行肠套叠复位行部分回肠切除术和端端吻合术。组织学检查未见浆膜表面有肿瘤细胞,但可见肿瘤细胞血管内侵犯。免疫组化标志物免疫组化阳性,诊断为 HCC 血行转移至回肠。第一次手术后 82 个月仍存活。
GI 道转移的 HCC 患者预后通常较差,但在某些情况下,多学科治疗可能延长生存。